Articles
| Open Access |
https://doi.org/10.37547/ijmsphr/Volume07Issue03-04
Modern Perspectives on The Impact of Comorbidities on The Course of Covid-19 In Children
Abstract
This article analyzes contemporary scientific literature regarding the impact of comorbidities on the course of COVID-19 in children. Obesity, diabetes mellitus, cardiovascular diseases, chronic lung diseases, neurological disorders, and immunodeficiency states are examined as independent risk factors for a severe course of COVID-19. Pathogenetic mechanisms, including cytokine storm, increased inflammatory markers, and T-cell immunity dysfunction, are described in detail. The article also highlights the clinical significance of MIS-C syndrome, its diagnostic criteria, modern treatment approaches, and vaccination recommendations.
Keywords
COVID-19, comorbidities, diabetes mellitus
References
World Health Organization. COVID-19 disease in children and adolescents. Scientific Brief. WHO/2019-nCoV/Sci_Brief/Children_and_adolescents/2021.2. Geneva: WHO, 2021.
Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;145 (6):e20200702. doi:10.1542/peds.2020-0702
Götzinger F, Santiago-García B, Noguera-Julián A, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020;4 (9):653-661.
Bixler D, Miller AD, Mattison CP, et al. SARS-CoV-2-Associated Deaths Among Persons Aged <21 Years - United States. MMWR Morb Mortal Wkly Rep. 2020;69 (37):1324-1329.
Centers for Disease Control and Prevention. COVID-19 Hospitalization and Death by Age. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-age.html. Accessed January 2024.
Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med. 2021;385 (3):239-250.
Butt AA, Dargham SR, Loka S, et al. COVID-19 Disease Severity in Children Infected With the Omicron Variant. Clin Infect Dis. 2022;75 (1):e361-e367.
Swann OV, Holden KA, Turtle L, et al. Clinical characteristics of children and young people admitted to hospital with COVID-19 in United Kingdom. BMJ. 2020;370:m3249.
Götzinger F, Ritz N, Tong SYC; LUMC COVID-19 Research. COVID-19 in children - understanding the immune responses and why they are less severe. NPJ Vaccines. 2022;7 (1):85.
Bhaskaran K, Bacon S, Evans SJ, et al. Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet Reg Health Eur. 2021;6:100109.
Henderson LA, Canna SW, Friedman KG, et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19. Arthritis Rheumatol. 2022;74 (4):e1-e20.
Feldstein LR, Tenforde MW, Friedman KG, et al. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021;325 (11):1074-1087.
Kompaniyets L, Agathis NT, Nelson JM, et al. Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children. JAMA Netw Open. 2021;4 (6):e2111182.
Caci G, Albini A, Malerba M, et al. COVID-19 and Obesity: Dangerous Liaisons. J Clin Med. 2020;9 (8):2511.
Unsworth R, Wallace S, Oliver NS, et al. New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K. Diabetes Care. 2020;43 (11):e170-e171.
Holman N, Knighton P, Kar P, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8 (10):823-833.
Accili D. Can COVID-19 cause diabetes? Nat Metab. 2021;3 (2):123-125.
Baumgarten-Martins M, Yared BS, Marques-Ramos A. COVID-19 and congenital heart disease: a review of the literature. Transl Pediatr. 2022;11 (5):801-812.
Fish R, Seegobin K, Bhatt P, et al. COVID-19 in Children With Cancer: Institutional and Systematic Review. J Pediatr Hematol Oncol. 2022;44 (3):e680-e686.
Rowley AH, Shulman ST. Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children. Nat Rev Immunol. 2021;21 (10):639-645.
Tosif S, Neeland MR, Sutton P, et al. Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19. Nat Commun. 2020;11 (1):5703.
Woodruff RC, Campbell AP, Taylor CA, et al. Risk Factors for Severe COVID-19 in Children. Pediatrics. 2022;149 (1):e2021053418.
Goldman DL, Aldrich ML, Hagmann SHF, et al. Compassionate Use of Remdesivir in Children With Severe COVID-19. Pediatrics. 2021;147 (5):e2020047803.
RECOVERY Collaborative Group; Horby P, Lim WS, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384 (8):693-704.
Laventhal N, Baxt R, Andrews BL, et al. The Ethics of Creating a Resource Allocation Strategy During the COVID-19 Pandemic. Pediatrics. 2020;146 (1):e20201243.
Рахматуллаева, Ш. Б., Муминова, М. Т., Нурматов, А. Х., & Саъдуллаев, С. Э. (2023). Особенности течения COVID-19 у детей с коморбидной патологией. Педиатрия. Восточная Европа,(3 Часть 12), 436-442.
Матякубов, Б. Б., & Ниязметов, Р. Э. СОВРЕМЕННЫЕ АСПЕКТЫ ЛЕЧЕНИЯ МАССИВНОГО АКУШЕРСКОГО КРОВОТЕЧЕНИЯ В ИССЛЕДУЕМОЙ ГРУППЕ. МИНИСТЕРСТВО ЗДРАВООХРАНЕНИЯ РЕСПУБЛИКИ УЗБЕКИСТАН РЕСПУБЛИКАНСКИЙ СПЕЦИАЛИЗИРОВАННЫЙ НАУЧНО-ПРАКТИЧЕСКИЙ МЕДИЦИНСКИЙ ЦЕНТР АКУШЕРСТВА И ГИНЕКОЛОГИИ АССОЦИАЦИЯ ВРАЧЕЙ ЧАСТНОЙ ПРАКТИКИ УЗБЕКИСТАНА КЛИНИКА «MAHLIYO-SHIFO» & V, 23.
NIYAZMETOV, R., MATYAKUBOV, B., NAZAROV, B., & USINOVA, Z. MASSIVE OBSTETRIC BLEEDING: OPTIMIZATION OF TOTAL HYSTERECTOMY SURGERY TECHNIQUE AND CONSERVATIVE TREATMENT. INFUSION & CHEMOTHERAPY Учредители: Communicable Diseases Intensive Care Association, (3.1), 55-56.
Максумова, Н. Б., Ниязметов, Р. Э., Матякубов, Б. Б., & Усинова, З. Б. (2019). РОЛЬ МЕСТНОГО ИСПОЛЬЗОВАНИЯ КОНЪЮГИРОВАННОГО ЭСТРОГЕНА В УЛУЧШЕНИИ ИСХОДОВ ОПЕРАТИВНОГО ЛЕЧЕНИЯ ПРОЛАПСА ГЕНИТАЛИЙ. Innova, (2 (15)), 20-23.
Matyakubov, B. B., Niyazmetov, R. E., Khabibullaev, D. M., & Usinova, Z. B. (2021). SURGICAL TACTICS FOR MASSIVE OBSTETRIC BLEEDING. European Journal of Molecular and Clinical Medicine, 8(2), 594-600.
Sadullayev, S. E. (2023). Characteristics of Pathomorphological Changes in Lymphocytic Leukosis in Children. European Scholar Journal, 4(12), 12-14.
Ernazarovich, S. S., Zarifboyevich, O. S., Rustombekovich, N. R., & Kadamovna, A. D. (2025). DYNAMICS OF THE COVID-19 PANDEMIC AND ITS CLINICAL CONSEQUENCES. Multidisciplinary Journal of Science and Technology, 5(5), 85-90.
Kadamovna, A. D., Rustombekovich, N. R., Zarifboyevich, O. S., & Ernazarovich, S. S. (2025). COMBINATIONS OF HEPATITIS B WITH PULMONARY TUBERCULOSIS. Multidisciplinary Journal of Science and Technology, 5(5), 60-65.
Rustombekovich, N. R., Zarifboyevich, O. S., Kadamovna, A. D., & Ernazarovich, S. S. (2025). THE STATE OF THE ANTIOXIDANT DEFENSE SYSTEM IN CHRONIC HEPATITIS C. Multidisciplinary Journal of Science and Technology, 5(5), 79-84.
Артиков, И. А., Отажанов, Ш. З., & Садуллаев, С. Э. (2025). ПАТОМОРФОЛОГИЧЕСКИЕ АСПЕКТЫ ДЕТСКОГО ЛИМФОБЛАСТНОГО ЛЕЙКОЗА. Multidisciplinary Journal of Science and Technology, 5(6), 257-264.
Sadullayev, S. E., Artikova, D. O., & Sadullayeva, M. R. (2026, January). STRENGTHENING CLINICAL REASONING IN INFECTIOUS DISEASES. In Scottish International Conference on Multidisciplinary Research and Innovation–SICMRI 2025 (Vol. 3, No. 1, pp. 19-21).
Article Statistics
Downloads
Copyright License
Copyright (c) 2026 Rakhmatullaeva Shaxnoza Baxadirovna, Sadullaev Siroj Ernazarovich, Qurbonov Bunyod Shavkatovich, Gullieva Nozima Shavkatovna
This work is licensed under a Creative Commons Attribution 4.0 International License.